The Market size of the Global Mini Bioreactors and Micro Bioreactors Market is predicted to show a 11.2% CAGR during the forecast period.
Traditional methods for growing microbial cells have lagged behind automated technologies based on arrays for manipulating DNA and uncovering biological systems. Systems that enable optimization, quick testing, and bioprocess development in low volume, parallel research with setup, and in a short amount of time are therefore required. These systems must also stay almost independent of the number of bioreactors. Micro bioreactors are a step toward developing high-throughput bioprocesses. They are made by combining automated sensors and actuators with polymer-based micro bioreactor manufacturing, design, production, and characterization processes. The micro bioreactors combine manufactured polymer micro-optical lenses and plug-and-flow microfluidic connectors for quick setup and simplicity of use. Micro bioreactors can also be used in a variety of ways to cultivate microbial cells for batch, continuous, and fed-batch operations. The usage of this approach for the generation of various byproducts is predicted to increase, leading to a significant increase in the global micro bioreactors market's revenue over the ensuing years. With a growth in R&D investment in the industrial and life sciences sectors, notably in the pharmaceutical and food and beverage sector, it is projected that the need for micro bioreactor technology would expand.
Additionally, compared to large-scale fermentations, micro bioreactors offer flexibility and controller of bench-scale reactors, resulting in quicker and more accurate results. The availability of online cultivation data, as well as other benefits offered by manufacturers such as a small footprint and the opportunity for automation, are anticipated to drive up demand for micro bioreactors throughout the course of the projection period. Nevertheless, despite the fact that the micro bioreactors industry is anticipated to experience significant growth throughout the projected period, regulatory issues could restrain the market's expansion. Additionally, emerging nations' lack of knowledge and experience could slow the rate of revenue growth over the forecast period.
The Mini Bioreactors and Micro Bioreactors market is segmented on the basis of distribution by type of cell culture, mode of operation, and end-user. Based on distribution by type of cell culture, the market is segmented as Mammalian, Microbial, Viral, Insect, and Others. By mode of operation, the market is segmented into Batch/Fed-Batch, and Continuous. By end-user, the market is segmented into Biopharmaceutical Industry and Academic Institutes.
Based on end-user, the Academic Institutes segment is accounted as a major contributor in the Mini Bioreactors and Micro Bioreactors market.
Micro-Bioreactors are widely used in academic institutes to provide live exposure to technical knowledge to students or professionals. Most educational institutions in the health, pharmaceutical, food, and chemical industries are expanding, emphasizing new technologies to satisfy market demands for sustainable technology. During the projected period, there will be a considerable increase in the demand for micro bioreactors from Academic institutions around the world due to the significant increase in their investments in research activities in targeted medicines, regenerative medicines, and cell culture medium.
Microbial segment witnessed growth at a rapid rate.
Shake flasks and microliter plates are used for primary and secondary screening investigations based on microbial libraries. The selection of the most promising microbial strain candidates is aided by this screening procedure. Selected microbial candidates are subsequently subjected to laboratory-scale experimental settings to enhance bioprocess control. After successful lab-scale testing, the micro bioreactor-developed bioprocess technology is scaled up to the pilot level. Pilot-scale testing is essential to grasp the bioreactor inhomogeneities, which may eventually be addressed using simulators that can scale down the bioreactor process. These improvements in procedures are accelerating the market's growth in the microbiological sector.
In the region, the North America Mini Bioreactors and Micro Bioreactors market hold a significant revenue share.
Owing to the inclusion of industry participants, the small-scale bioreactors market in North America is anticipated to grow significantly over the next years. For instance, on July 15, 2021, the H.E.L Group (H.E.L), a developer and manufacturer of tools used in laboratories for processing optimization, scale-up, and safety, announced that the company had expanded its operations to include sales, instrument service, and technical and field application support in regions of North America by opening a West Coast hub in California and a Central Region hub in Missouri.
Furthermore, due to significant technological developments made in the field of bioprocessing systems and the rising popularity of micro-bioreactors, North America dominated the global market. The region's wealth of biopharmaceutical companies and equipment suppliers is another factor contributing to North America's dominance in the global micro-bioreactors market.
Local enterprises stoked demand for micro-bioreactors in the area, and it is anticipated that demand will continue strong in the anticipated years.
The key players in the Mini Bioreactors and Micro Bioreactors market have shifted their focus towards bio-based components for product manufacturing and are initiating significant strategies such as mergers, acquisitions, and joint ventures of major and domestic players to enhance product portfolio and strengthen their market footprint across the globe. Some of the major key players in the Mini Bioreactors and Micro Bioreactors market are Sartorius AG, Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Lonza Group, Eppendorf AG, Miltenyi Biotec, Getinge AB, Solaris Biotechnology Srl, Infors AG, Biosan, MicroDigital Co., Ltd., 2mag AG, MDX Biotechnik International GmbH, Esco Lifesciences Group, HiTec Zang GmbH, Hanil Scientific Inc., Adolf Kühner AG, Ori Biotech, Aglaris, and AdvaBio.